MXCT
MaxCyte, Inc. · Healthcare
President and CEO Douglas Doerfler sold $51K of MaxCyte, Inc.
Sold$51,110
$5.02Price
10,177Shares
−3%Stake
What MXCT did after the filing
- The stock from Tue, Apr 4 close, $4.95
- −23.0%
- S&P 500, same days
- +1.6%
Measured over 30 trading days, to the May 17 close.
Traded Fri, Mar 31. Filed Tue, Apr 4, 2:59 PM ET, during the session. Returns use the Apr 4 close and the May 17 close. Not investment advice.